SNY•benzinga•
Why Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?
Summary
Sanofi's rilzabrutinib receives FDA orphan drug designation for two rare diseases. Clinical studies show meaningful response rates and reduced disease flares.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 3, 2025 by benzinga